Atomistry » Sodium » PDB 5vbx-5vxa » 5vof
Atomistry »
  Sodium »
    PDB 5vbx-5vxa »
      5vof »

Sodium in PDB 5vof: Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban

Enzymatic activity of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban

All present enzymatic activity of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban:
3.4.21.6;

Protein crystallography data

The structure of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban, PDB code: 5vof was solved by S.Krishnaswamy, S.Kumar, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 37.05 / 2.25
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 55.744, 164.275, 124.521, 90.00, 90.00, 90.00
R / Rfree (%) 22 / 25.3

Other elements in 5vof:

The structure of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban also contains other interesting chemical elements:

Fluorine (F) 19 atoms
Magnesium (Mg) 2 atoms
Calcium (Ca) 1 atom
Chlorine (Cl) 1 atom

Sodium Binding Sites:

The binding sites of Sodium atom in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban (pdb code 5vof). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total only one binding site of Sodium was determined in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban, PDB code: 5vof:

Sodium binding site 1 out of 1 in 5vof

Go back to Sodium Binding Sites List in 5vof
Sodium binding site 1 out of 1 in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban within 5.0Å range:
probe atom residue distance (Å) B Occ
H:Na302

b:46.6
occ:1.00
O H:TYR185 2.3 41.7 1.0
O H:HOH421 2.4 40.4 1.0
O H:LYS224 2.5 45.4 1.0
O H:ARG222 2.5 49.3 1.0
O H:HOH419 2.5 32.9 1.0
O H:ASP185A 2.7 50.0 1.0
C H:TYR185 3.5 42.9 1.0
C H:ARG222 3.6 50.9 1.0
C H:ASP185A 3.6 49.6 1.0
C H:LYS224 3.6 43.0 1.0
O H:HOH433 3.8 33.9 1.0
C H:ALA221 3.8 48.8 1.0
N H:ARG222 4.0 49.8 1.0
O H:ALA221 4.1 51.0 1.0
N H:LYS224 4.1 46.6 1.0
CA H:ALA221 4.1 47.3 1.0
CA H:ASP185A 4.2 47.8 1.0
N H:ASP185A 4.3 44.8 1.0
CA H:LYS224 4.4 45.6 1.0
CA H:ARG222 4.4 52.3 1.0
N H:LYS223 4.4 52.4 1.0
N H:THR185B 4.4 49.9 1.0
CA H:LYS223 4.5 53.9 1.0
O H:LYS186 4.5 47.9 1.0
CA H:TYR185 4.6 42.3 1.0
N H:TYR225 4.6 41.8 1.0
N H:GLY223A 4.6 51.5 1.0
N H:TYR185 4.6 40.8 1.0
CA H:TYR225 4.7 39.6 1.0
CB H:LYS224 4.8 46.3 1.0
CA H:THR185B 4.8 52.2 1.0
C H:LYS223 4.8 53.5 1.0
CB H:TYR185 4.9 42.1 1.0
N H:ALA221 4.9 45.6 1.0

Reference:

R.Gunaratne, S.Kumar, J.W.Frederiksen, S.Stayrook, J.L.Lohrmann, K.Perry, K.M.Bompiani, C.V.Chabata, N.K.Thalji, M.D.Ho, G.Arepally, R.M.Camire, S.Krishnaswamy, B.A.Sullenger. Combination of Aptamer and Drug For Reversible Anticoagulation in Cardiopulmonary Bypass. Nat. Biotechnol. V. 36 606 2018.
ISSN: ISSN 1546-1696
PubMed: 29863725
DOI: 10.1038/NBT.4153
Page generated: Tue Oct 8 00:53:06 2024

Last articles

Zn in 9MJ5
Zn in 9HNW
Zn in 9G0L
Zn in 9FNE
Zn in 9DZN
Zn in 9E0I
Zn in 9D32
Zn in 9DAK
Zn in 8ZXC
Zn in 8ZUF
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy